Search - tctmd.com

Displaying 1 - 20 of 194

Sort: Relevancy | Date

News Daily News

JACC Debuts Data Digest on CV Health in the United States

Caitlin E. Cox

January 12, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Conference News AHA 2025

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

Todd Neale

November 13, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Daily News

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

Yael L. Maxwell

May 15, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

MI Care Varies Across Asian Subgroups in the US

Yael L. Maxwell

September 19, 2024

News Conference News SCCT 2024

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Todd Neale

July 25, 2024

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Opinion CV Team Dispatch

July 2024 Dispatch for the CV Team

L.A. McKeown

July 01, 2024

News Daily News

Risk of Death Remains Low a Decade After Primary PCI for STEMI

Caitlin E. Cox

June 18, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Industry News

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

May 29, 2024

News Conference News AHA 2023

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Shelley Wood

November 11, 2023

News Conference News EuroPCR 2023

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Michael O'Riordan

May 19, 2023

News Daily News

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

Michael O'Riordan

May 09, 2023

News Conference News ACC 2023

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

L.A. McKeown

March 09, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

Advertisement

JACC Debuts Data Digest on CV Health in the United States

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Prasugrel May Be Better Than Ticagrelor After PCI for Diabetes Patients With MVD

What’s Going to Be Hot at TCT 2025

Procedural MIs Have Little Effect on Quality of Life: ISCHEMIA

April 2025 Dispatch for the CV Team

October 2024 Dispatch for the CV Team

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

MI Care Varies Across Asian Subgroups in the US

AI Assessment of Plaque, Hemodynamics May ID Lesion-Specific ACS Risk

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

July 2024 Dispatch for the CV Team

Risk of Death Remains Low a Decade After Primary PCI for STEMI

June 2024 Dispatch for the CV Team

CellProthera announces positive Phase I/IIb data for ProtheraCytes® cell therapy in acute myocardial infarction

DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI

Meta-analysis Finds No Excess Mortality Risk With Coronary Revascularization

Enough PCI ‘Versus’ CABG—Time to Focus on Understudied Groups

AIMI-HF Misses Mark With Advanced Imaging in Ischemic HFrEF Workup

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content